The results obtained using NT coupled with 68Ga for the detection of colon cancer and the potential of this peptide to be used in therapy coupled with 177Lu are arguments to extend the studies of this peptide as a potential theranostic agent, with and without having the peptidases previously inhibited. This evidence concerns the gene LAP3 and malignant colon neoplasm.